MORTIMER IAN
SEC insider (Form 3/4/5 filer). CIK 0001619961. PRESIDENT & CEO at Xenon Pharmaceuticals Inc. (XENE). 40 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in BURNABY.
Companies MORTIMER IAN has filed insider reports for
- Xenon Pharmaceuticals Inc. (XENE): Director, Officer, PRESIDENT & CEO
MORTIMER IAN
CIK: 0001619961
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xenon Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (40 total)
- Sep 30, 2026XENE
Xenon Pharmaceuticals Inc.
PurchaseDirect30K shares at avg. $37.38$1.1M - Mar 13, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect7.3K shares at avg. $55.23$404K - Mar 12, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect12.5K shares- - Mar 10, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect11.3K shares at avg. $60.11$677K - Mar 9, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect12.5K shares at avg. $59.50$743K - Mar 9, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect25K shares at avg. $3.10$78K - Mar 9, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect105K shares at avg. $4.75$499K - Mar 9, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect75K shares at avg. $8.40$630K - Mar 9, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect10.1K shares at avg. $60.47$609K - Mar 9, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect21.8K shares at avg. $58.81$1.3M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | XENE Xenon Pharmaceuticals Inc. | Purchase | 30,000 | $37.38 | $1,121,400 | Direct |
| Mar 13, 2026 | XENE Xenon Pharmaceuticals Inc. | Sale | 7,308 | $55.23 | $403,584 | Direct |
| Mar 12, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 12,500 | - | $0 | Direct |
| Mar 10, 2026 | XENE Xenon Pharmaceuticals Inc. | Sale | 11,269 | $60.11 | $677,357 | Direct |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc. | Sale | 12,479 | $59.50 | $742,501 | Direct |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 25,000 | $3.10 | $77,500 | Direct |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 105,000 | $4.75 | $498,750 | Direct |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 75,000 | $8.40 | $630,000 | Direct |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc. | Sale | 10,072 | $60.47 | $609,054 | Direct |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc. | Sale | 21,791 | $58.81 | $1,281,529 | Direct |
1-10 of 40 transactions